siRNA Targeting against EGFR, a Promising Candidate for a Novel Therapeutic Application to Lung Adenocarcinoma

Publisher： Karger

E-ISSN： 1423-0291|75|1|2-8

ISSN： 1015-2008

Source： Pathobiology, Vol.75, Iss.1, 2008-03, pp. : 2-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MCM2 and Ki-67 Expression in Human Lung Adenocarcinoma: Prognostic Implications

By  

Pathobiology, Vol. 71, Iss. 4, 2004-07 ,pp. : 193-200

Karger

Access to resources Recommend Favorite

Bispecific Antibodies: Molecules That Enable Novel Therapeutic Strategies

By  

Pathobiology, Vol. 74, Iss. 1, 2007-05 ,pp. : 3-14

Karger

Access to resources Recommend Favorite

Application of Novel Biomaterials in Clinical Surgery

By  

Pathobiology, Vol. 80, Iss. 4, 2013-05 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

Expression of the Mammalian Target of Rapamycin Pathway Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma

By  

Pathobiology, Vol. 79, Iss. 2, 2012-01 ,pp. : 84-93

Karger

Access to resources Recommend Favorite

Cortical Actin Alteration at the Matrix-Side Cytoplasm in Lung Adenocarcinoma Cells and Its Significance in Invasion

By  

Pathobiology, Vol. 84, Iss. 4, 2016-12 ,pp. : 171-183

Karger

Access to resources Recommend Favorite